Exploratory study about the influence of drug administration guidance on patients satisfaction with treatment after administration of Mirogabali

Phase 4

Recruiting

Conditions: europathic pain due to orthopedic diseases

Registration Number: JPRN-jRCTs041230059

Lead Sponsor: akashima Hiroaki

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 200

Inclusion Criteria

1. Patients diagnosed with neuropathic pain due to orthopedic disorders
2. First patient treated with a neuropathic pain medication
3. Patients who are scheduled to continue treatment for at least 8 weeks and are able to attend the relevant medical institution
4. Patients aged 18 years or older at the time of obtaining informed consent
5. Patients who can understand the procedure of this study, answer questions in Japanese appropriately in writing and by electromagnetic means (ePRO) without assistance, and give their own written consent on their own free will to participate in this study by writing or electromagnetic means (eConsent)

Exclusion Criteria

1. Patients who are considered to require inpatient treatment at the time of study entry
2. Patients scheduled to undergo surgery during the study period
3. Patients with severe pain attributable to a disease other than the relevant disease and considered difficult to evaluate.
4. Patients with creatinine clearance (CLcr) <30 mL/min
5. Patients with complicated serious liver, kidney, and heart disease
6. Patients who are pregnant or possibly pregnant at the time of obtaining informed consent, patients who are breastfeeding at the time of obtaining informed consent, and patients who intend to become pregnant within 6 months after obtaining informed consent
7. Patients participating in or planned to participate in other intervention studies at enrollment
8. Other patients judged by the principal investigator or subinvestigator to be ineligible for participation in this study